Virological Markers in Epstein–Barr Virus-Associated Diseases
Epstein–Barr virus (EBV) is an oncogenic virus infecting more than 95% of the world’s population. After primary infection—responsible for infectious mononucleosis in young adults—the virus persists lifelong in the infected host, especially in memory B cells. Viral persistence is usually without clin...
Main Authors: | Julien Lupo, Aurélie Truffot, Julien Andreani, Mohammed Habib, Olivier Epaulard, Patrice Morand, Raphaële Germi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/3/656 |
Similar Items
-
Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine
by: Vincent Jean-Pierre, et al.
Published: (2021-06-01) -
Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in Vitória, State of Espírito Santo, Brazil
by: Cecília M. Figueira-Silva, et al.
Published: (2004-10-01) -
Epstein-Barr virus: the molecular virology and the associated diseases
by: Takayuki Murata
Published: (2023-05-01) -
Raman spectroscopy of lymphocytes from patients with the Epstein–Barr virus infection
by: Magdalena Pietruszewska, et al.
Published: (2024-03-01) -
Chronic Active Epstein–Barr Virus Disease
by: Hiroshi Kimura, et al.
Published: (2017-12-01)